Objective. The aim of this study was to evaluate the impact of surgical sta
ging in the treatment and outcome of women with Locally advanced cervical c
ancer.
Methods, Ninety-eight women with locally advanced cervical cancer treated b
etween 1993 and 1997 were retrospectively reviewed. Survival probabilities
were calculated by the Kaplan-Meier product limit method and compared with
the log-rank test.
Results. Of the 98 women treated over the 5-year period, 86 were surgically
staged: 61 by a retroperitoneal approach, 18 by larparoscopy, and 7 by lap
arotomy. Median blood loss was 120 cc and median length of hospitalization
was 3 days. Preoperative CT scans (n = 55), when compared with surgical fin
dings, missed macroscopic nodal disease in 20% and microscopic disease in 1
5% and overcalled disease in 10% of cases. Lymph node metastases were found
in 45/86 patients (52%): 12 microscopic and 33 macroscopic. The highest le
vel of nodes found to be involved was pelvic in 23, common iliac nodes in 3
, para-aortic nodes in 14, and scalene nodes in 5 cases. Of the 86 patients
, 49 received pelvic radiation, 27 received extended field radiation, and 1
0 were identified for palliative treatment only (5 scalene node metastasis,
5 extensive intraperitoneal disease). For node-negative patients, 5-year s
urvival was 74%; for microscopic nodal involvement it was 58%; and for macr
oscopic involvement it was 39% (P = 0.007). Five-year survival for women wi
th para-aortic node involvement was 52%. Number of nodes involved was a sig
nificant prognostic variable (P = 0.008). Patients who received chemotherap
y had a 5-year survival of 68% compared to 35% for those who did not (P = 0
.06). Factors which did not affect survival included age, histology, type o
f surgery, stage, and type of radiation (pelvic vs extended).
Conclusion. Surgical staging of women with locally advanced cervical cancer
can be performed with acceptable morbidity and it provided more accurate i
nformation than CT scans and resulted in a modification of the standard pel
vic radiation field for 43% of our patients. The information obtained from
surgical staging allows better individualization of therapy, which may impr
ove overall clinical outcome. a (C) 1999 Academic Press.